Submission Preparation ChecklistAs part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
- The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
- Where available, URLs for the references have been provided.
- The text employs italics for foreign phrases, and bold for emphasis rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
- If submitting to a peer reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
If the article will be accepted for publication, the Authors will sign and send to the Publisher the Publication Agreement (downloadable here)
The Authors will also sign and send to the Publisher the International Committee of Medical Journal Editors (ICMJE) form for Disclosure of Potential Conflicts of Interest (downloadable here)
Editorials are short articles on issues of topical importance. They aim at offering a personal perspective on a topic of recent interest. Therefore, we encourage our editorial writers to express their opinions, giving the author the opportunity to present criticism or address controversy.
Figures and tables can be included in editorials, if necessary. Word limit: about 1,000-1,500 words
Original researches include original works of research and analysis especially regarding economic evaluations such as cost-effectiveness, cost-utility, cost effectiveness analysis, and budget impact model. The articles should include description of how the data of cost was identified and quantified and, in case of a budget impact model, how the model was structured.
A structured abstract of less than 300 words is required. The text is limited to about 6,000 words (not including abstract, tables, figures, and references); about 6 tables (a detail of cost data input and of results should be included), and there are no reference limits.
Review (Economic Analysis)
Review should be focused on a specific drug, class of drugs, or pathology.
Reviews on specific drug or class of drugs must include clinical issue and therapeutic role. Pharmacoeconomic profile and synthesis of the available economic evidence should receive the greatest emphasis.
Reviews on pathology must include clinical issue and therapeutic options; cost of illness should receive the greatest emphasis.
An abstract of less than 300 words is required. The text is limited to about 6,000 words (not including abstract, tables, figures, and references); about 6 tables, and no reference limit.
Articles should focus on specific methods and techniques used in economic analysis. Principles and applications of the techniques must be illustrated and practical examples of use should be reported.
An abstract of less than 300 words is required. The text is limited to 4,000 words (not including abstract, tables, figures, and references); about 3-4 tables, and no reference limit.
Focus On articles should cover an aspect of an issue that is relevant to the journal’s readership. For example it could be a discussion on the adoption of a new technology, or on issue concerned pricing and reimbursement. This section also include small-scale researches, preliminary results or brief reports that bring out a message adequate for the journal's scope and of particular interest to the community.
An unstructured abstract of less than 300 words is required. The text is limited to 1,500-3,000 words (not including abstract, tables, figures, and references); max 2 tables/figures, and no reference limits.
Brief drug profile
It’s a brief review on the clinical and pharmacoeconomic aspects of a specific drug. The article should begin with a brief discussion on the disease for which the drug has received the indication. In case of two or more indications in each article will be discussed only one. Indication and dosing, pharmacokinetics, pharmacodynamics, efficacy and safety should be reported. Pharmacoeconomics profile should be focus on review of economic evaluations of the drug or the cost of illness, if economic analysis are not available in literature.
The text is limited to 3,000 words (not including tables and references); about 3 tables, and no reference limit.
Letter to the Editor
Letter to the Editor should reports comments on papers published in Farmeconomia. Health Economics and Therapeutic Pathways. They should contain substantive ideas and commentary supported by appropriate data and references. Whenever possible, they will be published with the reply of the published paper's author.
No abstract is required. The text is limited to 1,000 words; max 2 tables/figures, and no reference limit.
SupplementPublished supplements are fully searchable and freely accessible online.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
- Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)
It is SEEd Srl’s policy to respect your privacy regarding any information we may collect while operating our websites. Owner of the processing of personal data is SEEd srl (Via Magenta, 35 - 10128 Turin, Italy).
In compliance with the General Data Protection Regulation (GDPR - EU 2016/679), we inform you that the names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal (online submissions, editorial workflow tracking, call for papers, online publication, and updates) and will not be made available for any other purpose or to any other party. Only with your optional consent, you will receive notices for the publication of new issues. You have the right, at any time and free of charge, to ask the data controller to access your personal data, correct or delete them and limit their processing. Furthermore, you have the right to restrict certain processing, to object to your personal data being processed for direct marketing purposes, to the portability of data and to propose a complaint to a supervisory authority.
For more information, please refer to the page http://www.seedmedicalpublishers.com/privacy-statement-cookies-policy/